-
1
-
-
24344445873
-
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas
-
Cullen M, Steven N, Billingham L, et al: Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 353:988-998, 2005
-
(2005)
N Engl J Med
, vol.353
, pp. 988-998
-
-
Cullen, M.1
Steven, N.2
Billingham, L.3
-
2
-
-
24344471724
-
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia
-
Bucaneve G, Micozzi A, Menichetti F, et al: Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 353:977-987, 2005
-
(2005)
N Engl J Med
, vol.353
, pp. 977-987
-
-
Bucaneve, G.1
Micozzi, A.2
Menichetti, F.3
-
3
-
-
33750042267
-
Antibiotic Prophylaxis in Neutropenic Patients: New evidence, practical decisions
-
Leibovici L, Paul M, Cullen MH, et al: Antibiotic Prophylaxis in Neutropenic Patients: New evidence, practical decisions. Cancer 107:1743-1751, 2006
-
(2006)
Cancer
, vol.107
, pp. 1743-1751
-
-
Leibovici, L.1
Paul, M.2
Cullen, M.H.3
-
4
-
-
0028986117
-
Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin
-
Carratalá J, Fernandez-Sevilla A, Tubau F, et al: Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin. Clin Infect Dis 20:557-560, 1995
-
(1995)
Clin Infect Dis
, vol.20
, pp. 557-560
-
-
Carratalá, J.1
Fernandez-Sevilla, A.2
Tubau, F.3
-
5
-
-
0028344856
-
Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia
-
Cometta A, Calandra T, Bille J, et al: Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. N Engl J Med 330:1240-1241, 1994
-
(1994)
N Engl J Med
, vol.330
, pp. 1240-1241
-
-
Cometta, A.1
Calandra, T.2
Bille, J.3
-
6
-
-
0024809041
-
Antimicrobial susceptibility of viridans group streptococci isolated from patients with acute leukemia receiving ofloxacin for antibacterial prophylaxis
-
Kern W, Linzmeier K, Kurrle E: Antimicrobial susceptibility of viridans group streptococci isolated from patients with acute leukemia receiving ofloxacin for antibacterial prophylaxis. Infection 17:396-397, 1989
-
(1989)
Infection
, vol.17
, pp. 396-397
-
-
Kern, W.1
Linzmeier, K.2
Kurrle, E.3
-
7
-
-
16844386485
-
Fluoroquinolone resistance of Escherichia coli at a cancer center: Epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia
-
Kern WV, Klose K, Jellen-Ritter AS, et al: Fluoroquinolone resistance of Escherichia coli at a cancer center: Epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia. Eur J Clin Microbiol Infect Dis 24:111-118, 2005
-
(2005)
Eur J Clin Microbiol Infect Dis
, vol.24
, pp. 111-118
-
-
Kern, W.V.1
Klose, K.2
Jellen-Ritter, A.S.3
-
8
-
-
0027435085
-
Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin
-
McWhinney PH, Patel S, Whiley RA, et al: Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin. Antimicrob Agents Chemother 37:2493-2495, 1993
-
(1993)
Antimicrob Agents Chemother
, vol.37
, pp. 2493-2495
-
-
McWhinney, P.H.1
Patel, S.2
Whiley, R.A.3
-
10
-
-
41049093347
-
The combination of estimates from different experiments
-
Cochran WG: The combination of estimates from different experiments. Biometrics 10:101-129, 1954
-
(1954)
Biometrics
, vol.10
, pp. 101-129
-
-
Cochran, W.G.1
-
11
-
-
0036467835
-
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer
-
Holmes FA, O'Shaughnessy JA, Vukelja S, et al: Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer. J Clin Oncol 20:727-731, 2002
-
(2002)
J Clin Oncol
, vol.20
, pp. 727-731
-
-
Holmes, F.A.1
O'Shaughnessy, J.A.2
Vukelja, S.3
-
12
-
-
0035189248
-
Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study
-
Tjan-Heijnen VC, Postmus PE, Ardizzoni A, et al: Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study. Ann Oncol 12:1359-1368, 2001
-
(2001)
Ann Oncol
, vol.12
, pp. 1359-1368
-
-
Tjan-Heijnen, V.C.1
Postmus, P.E.2
Ardizzoni, A.3
-
13
-
-
32944482839
-
Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: A Dutch randomized phase III study
-
Timmer-Bonte JN, de Boo TM, Smit HJ, et al: Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: A Dutch randomized phase III study. J Clin Oncol 23:7974-7984, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 7974-7984
-
-
Timmer-Bonte, J.N.1
de Boo, T.M.2
Smit, H.J.3
-
14
-
-
14544270307
-
First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: A multicenter, double-blind, placebo-controlled phase III study
-
Vogel CL, Wojtukiewicz MZ, Carroll RR, et al: First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: A multicenter, double-blind, placebo-controlled phase III study. J Clin Oncol 23:1178-1184, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 1178-1184
-
-
Vogel, C.L.1
Wojtukiewicz, M.Z.2
Carroll, R.R.3
-
15
-
-
0345604387
-
Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate grade non-Hodgkin lymphoma
-
Lyman GH, Delgado DJ: Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate grade non-Hodgkin lymphoma. Cancer 98:2402-2409, 2003
-
(2003)
Cancer
, vol.98
, pp. 2402-2409
-
-
Lyman, G.H.1
Delgado, D.J.2
-
16
-
-
33645550926
-
First cycle risk of severe and febrile neutropenia in cancer patients receiving systemic chemotherapy: Results from a prospective nationwide study
-
abstr 2210
-
Crawford J, Wolff DA, Culakova E, et al: First cycle risk of severe and febrile neutropenia in cancer patients receiving systemic chemotherapy: Results from a prospective nationwide study. Proc Am Soc Hematol 104, 2004 (abstr 2210)
-
(2004)
Proc Am Soc Hematol
, vol.104
-
-
Crawford, J.1
Wolff, D.A.2
Culakova, E.3
-
17
-
-
33748442136
-
Febrile neutropenia: Highlighting the role of prophylactic antibiotics and G-CSF during standard dose chemotherapy for solid tumors
-
Timmer-Bonte JN, Tjan-Heijnen VC: Febrile neutropenia: Highlighting the role of prophylactic antibiotics and G-CSF during standard dose chemotherapy for solid tumors. Anticancer Drugs 17:881-889, 2006
-
(2006)
Anticancer Drugs
, vol.17
, pp. 881-889
-
-
Timmer-Bonte, J.N.1
Tjan-Heijnen, V.C.2
-
18
-
-
33845876873
-
Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: Systematic review and metaanalysis
-
Gafter-Gvili A, Paul M, Fraser A, et al: Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: Systematic review and metaanalysis. J Antimicrob Chemother 59:5-22, 2007
-
(2007)
J Antimicrob Chemother
, vol.59
, pp. 5-22
-
-
Gafter-Gvili, A.1
Paul, M.2
Fraser, A.3
-
19
-
-
0031943040
-
Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom
-
Fossa SD, Kaye SB, Mead GM, et al: Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom. J Clin Oncol 16:716-724, 1998
-
(1998)
J Clin Oncol
, vol.16
, pp. 716-724
-
-
Fossa, S.D.1
Kaye, S.B.2
Mead, G.M.3
-
21
-
-
0347985317
-
Chemotherapy-induced neutropenia: Risks, consequences, and new directions for its management
-
Crawford J, Dale DC, Lyman GH: Chemotherapy-induced neutropenia: Risks, consequences, and new directions for its management. Cancer 100:228-237, 2004
-
(2004)
Cancer
, vol.100
, pp. 228-237
-
-
Crawford, J.1
Dale, D.C.2
Lyman, G.H.3
-
22
-
-
36049051974
-
Primary prophylaxis with 3 weekly pegfilgrastim and ciprofloxacin effectively prevent (febrile) neutropenia and infection during neoadjuvant chemotherapy with docetaxel/doxorubicin/cyclophosphamide (TAC) chemotherapy in breast cancer patients
-
suppl; abstr 8008, 731s
-
Von Minckwitz G, Blohmer J, Löhr A et al: Primary prophylaxis with 3 weekly pegfilgrastim and ciprofloxacin effectively prevent (febrile) neutropenia and infection during neoadjuvant chemotherapy with docetaxel/doxorubicin/cyclophosphamide (TAC) chemotherapy in breast cancer patients. J Clin Oncol 23:731s, 2005 (suppl; abstr 8008)
-
(2005)
J Clin Oncol
, vol.23
-
-
Von Minckwitz, G.1
Blohmer, J.2
Löhr, A.3
-
23
-
-
33746007143
-
Cost-effectiveness of adding granulocyte colonystimulating factor to primary prophylaxis with antibiotics in small-cell lung cancer
-
Timmer-Bonte JN, Adang EM, Smit HJ, et al: Cost-effectiveness of adding granulocyte colonystimulating factor to primary prophylaxis with antibiotics in small-cell lung cancer. J Clin Oncol 24:2991-2997, 2006
-
(2006)
J Clin Oncol
, vol.24
, pp. 2991-2997
-
-
Timmer-Bonte, J.N.1
Adang, E.M.2
Smit, H.J.3
|